Macromolecular Bioscience · 2016 · 20 citations · 43 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryPharmacokinetics Of Anticancer AgentsPolymer ChemistryCancer Drug DeliveryCancer NanomedicineDrug EncapsulationNanocarriers For TherapeuticsNanomedicineNanoparticle FormulationsAnticancer Drug LoadingBlock Copolymer MicellesDrug Delivery NanocarriersDrug-loaded MicellesMicelle Drug DeliveryMicellesNanocarriersPolymeric Micelles
Previously synthesized amphiphilic diblock copolymers with pendant dendron moieties have been investigated for their potential use as drug carriers to improve the delivery of an anticancer drug to human breast cancer cells. Diblock copolymer (P71 D3 )-based micelles effectively encapsulate the doxorubicin (DOX) with a high drug-loading capacity (≈95%, 104 DOX molecules per micelle), which is approximately double the amount of drug loaded into the diblock copolymer (P296 D1 ) vesicles. DOX released from the resultant P71 D3 /DOX micelles is approximately 1.3-fold more abundant, at a tumoral acidic pH of 5.5 compared with a pH of 7.4. The P71 D3 /DOX micelles also enhance drug potency in breast cancer MDA-MB-231 cells due to their higher intracellular uptake, by approximately twofold, compared with the vesicular nanocarrier, and free DOX. Micellar nanocarriers are taken up by lysosomes via energy-dependent processes, followed by the release of DOX into the cytoplasm and subsequent translocation into the nucleus, where it exert its cytotoxic effect.
43
Acid pH in tumors and its potential for therapeutic exploitation.
Ian F. Tannock, Daniela Rotin · PubMed · 1989 · 1.6K citations
Medicine, Oncology, Pharmacology +16
Caroline F. Thorn, Connie Oshiro, Sharon Marsh et al. · Pharmacogenetics and Genomics · 2010 · 1.6K citations · Full text
Polymeric micelles as drug delivery vehicles
Zaheer Ahmad, Afzal Shah, Muhammad Siddiq et al. · RSC Advances · 2014 · 596 citations · Full text